http://www.unboundmedicine.com/medline/ebm/research/interferon_alfacon_1Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19714721/full_citation/Re_treating_chronic_hepatitis_C_with_daily_interferon_alfacon_1/ribavirin_after_nonresponse_to_pegylated_interferon/ribavirin:_Really_safe_and_effectiveLo GH 
Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: Really safe and effective? [JOURNAL ARTICLE]
Hepatology 2009 Jun 15; 50(3):988.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19713984/full_citation/Hepatitis_C:_The_role_of_new_interferons_in_the_era_of_STAT_C_Moucari R, Marcellin P 
Hepatitis C: The role of new interferons in the era of STAT-C. [News]
Nat Rev Gastroenterol Hepatol 2009 Sep; 6(9):509-11.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19586556/full_citation/Efficacy_of_consensus_interferon_in_treatment_of_HbeAg_positive_chronic_hepatitis_B:_a_multicentre_randomized_controlled_trial_Zheng Y, Zhao L, Wu T, et al. 
Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial. [Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial]
Virol J 2009.:99.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19362605/full_citation/Treatment_Options_for_Patients_With_Chronic_Hepatitis_C_Not_Responding_to_Initial_Antiviral_Therapy_Jacobson IM 
Treatment Options for Patients With Chronic Hepatitis C Not Responding to Initial Antiviral Therapy. [JOURNAL ARTICLE]
Clin Gastroenterol Hepatol 2009 Apr 9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19291790/full_citation/Retreating_chronic_hepatitis_C_with_daily_interferon_alfacon_1/ribavirin_after_nonresponse_to_pegylated_interferon/ribavirin:_DIRECT_results_Bacon BR, Shiffman ML, Mendes F, et al. 
Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results. [JOURNAL ARTICLE]
Hepatology 2009 Feb 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19247202/full_citation/Thyroid_Disorders_and_Occurrence_of_Nonorgan_specific_Autoantibodies__NOSA__in_Patients_With_Chronic_Hepatitis_C_Before_and_During_Antiviral_Induction_Therapy_With_Consensus_Interferon__Interferon_Alfacon_1__Hass HG, Klein R, Nehls O, et al. 
Thyroid Disorders and Occurrence of Nonorgan-specific Autoantibodies (NOSA) in Patients With Chronic Hepatitis C Before and During Antiviral Induction Therapy With Consensus Interferon (Interferon Alfacon-1). [JOURNAL ARTICLE]
J Clin Gastroenterol 2009 Feb 25.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19233994/full_citation/Elevated_hepatic_transaminases_associated_with_the_use_of_interferon_alfacon_1_and_ribavirin_Kleppinger EL, Ragan AP 
Elevated hepatic transaminases associated with the use of interferon alfacon-1 and ribavirin. [Journal Article]
Am J Health Syst Pharm 2009 Mar 1; 66(5):465-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19057165/full_citation/A_case_of_ANCA_associated_vasculitis_induced_by_interferon_therapy_for_HCV_infection_Watanabe T, Oono Y, Takeshita E, et al. 
A case of ANCA associated vasculitis induced by interferon therapy for HCV infection. [JOURNAL ARTICLE]
Nippon Shokakibyo Gakkai Zasshi 2008; 105(12):1787-1793.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18985796/full_citation/Pharmacokinetic_properties_of_a_40_kDa_branched_polyethylene_glycol_modified_form_of_consensus_interferon_alpha__PEG_CIFN__in_rhesus_monkeys_Du Y, Tian H, Gao XD, et al. 
Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys. [JOURNAL ARTICLE]
Biopharm Drug Dispos 2008 Nov 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18837390/full_citation/[Expression_and_activity_analysis_of_interferonalpha_con_and_thymosin_alpha1]Liu X, Liu F, Li B, et al. 
[Expression and activity analysis of interferonalpha-con and thymosin-alpha1] [English Abstract, Journal Article]
Sheng Wu Gong Cheng Xue Bao 2008 Jul; 24(7):1168-73.
Abstract | Full Citation | Find Related Articles